PHAXIAM Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 95.9%.

Top 25 shareholders own 40.37% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.3%	Auriga Partners	807,886	US$2.5m	0%	36.48%
7.83%	Go Capital SAS	475,607	US$1.5m	0%	16.36%
7.77%	Tikehau Investment Management SAS	471,777	US$1.5m	0%	0.78%
3.16%	Akkadian Partners S.A.	191,995	US$597.8k	0%	no data
2.68%	Armistice Capital LLC	162,912	US$507.3k	0%	0.01%
0.9%	SAS Helea Financière	54,375	US$169.3k	0%	no data
0.71%	Recordati Orphan Drugs	43,103	US$134.2k	0%	no data
0.51%	Valentine Gouedard Comte	31,193	US$97.1k	0%	no data
0.43%	Solys	26,189	US$81.5k	0%	no data
0.4%	Myropola	24,042	US$74.9k	0%	no data
0.36%	OFI Asset Management SA	22,000	US$68.5k	0%	no data
0.28%	Aviva Investors Global Services Ltd.	16,886	US$52.6k	0%	no data
0.27%	MP Deloche & Associates SARL	16,100	US$50.1k	0%	no data
0.25%	Paminove	15,376	US$47.9k	0%	no data
0.25%	Sc Roc De Lou	15,108	US$47.0k	0%	no data
0.23%	Mathieu Bigois	13,700	US$42.7k	0%	no data
0.2%	Sofidu	11,854	US$36.9k	0%	no data
0.2%	Financiere Saint Romain	11,854	US$36.9k	0%	no data
0.16%	BVF Partners L.P.	9,734	US$30.3k	0%	no data
0.15%	Jacques Tcheng	9,016	US$28.1k	0%	no data
0.12%	Generali Asset Management SGR SpA	7,000	US$21.8k	0%	no data
0.099%	Française Asset Management	6,000	US$18.7k	0%	0.01%
0.056%	Friedland Gestion	3,375	US$10.5k	0%	0.18%
0.043%	Bernard Linage	2,626	US$8.2k	0%	no data
0.04%	BBVA Asset Management, S.A., S.G.I.I.C	2,453	US$7.6k	0%	no data